Search Results
Oct 10, 2025, 07:30 ET Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
syndrome of uncontrolled body movements in the face, tongue, or other body parts, which may increase with duration of treatment and total cumulative dose. TD may not go away, even if CAPLYTA is discontinued. It can also occur after CAPLYTA is discontinued. Metabolic
More news about: Johnson & Johnson
Oct 08, 2025, 17:44 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, for the treatment of adult patients with non-transfusion-dependent (NTD) and transfusion-dependent (TD) alpha- or beta-thalassemia by three months to December 7, 2025." On news of the delayed review, Agios's stock price fell $4.48
More news about: Pomerantz LLP
Oct 08, 2025, 07:00 ET Boston-Based Newforma Joins Forces with the Boston Bruins and TD Garden
management for the architecture, engineering, construction and owner (AECO) industry, today announced a multi-year partnership with the Boston Bruins and TD Garden.
More news about: Newforma
Oct 07, 2025, 07:06 ET Inspiring Journeys, Lasting Impact
Champion Sponsors: First Bank, Health Foundation of South Florida, Hispanic Federation, NUC Online Division, TD Bank, and Telemundo 51 About ProsperaProspera is an economic development,
More news about: Prospera
Oct 07, 2025, 07:00 ET SAVE BIG WITH SODASTREAM® THIS PRIME DAY
https://www.amazon.com/SodaStream-Sparkling-Bundle-Bottles-Flavors/dp/B097TD87ZY Terra Kit
More news about: Sodastream
Oct 06, 2025, 13:01 ET Deriva Energy Agrees to Sell 833MWdc of Operating Solar Assets to Clearway Energy
asset portfolio and recycle capital into our next phase of growth," said John Clapp, Chief Executive Officer of Deriva Energy. TD Securities acted as exclusive financial advisor to Deriva Energy and Manulife Investment Management. The transaction is expected
More news about: Deriva Energy
Oct 06, 2025, 08:30 ET Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea
for VMAT1, dopaminergic (including D2), serotonergic, adrenergic, histaminergic or muscarinic receptors. While the specific way INGREZZA works to treat TD and HD chorea is not fully understood, INGREZZA is unique in that it selectively and specifically targets VMAT2 to inhibit the release of dopamine, a
More news about: Neurocrine Biosciences, Inc.
Oct 06, 2025, 08:24 ET Sunoco LP Announces Commencement of Private Exchange Offers and Consent Solicitations for Outstanding Notes of Parkland Corporation
TD Securities (USA) LLC
More news about: Sunoco LP
Oct 03, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, for the treatment of adult patients with non-transfusion-dependent (NTD) and transfusion-dependent (TD) alpha- or beta-thalassemia by three months to December 7, 2025." On news of the delayed review, Agios's stock price fell $4.48
More news about: Pomerantz LLP
Oct 03, 2025, 08:00 ET indiGOtech Secures Strategic Investment from Passkey to Become America's First Vertically Integrated Smart Mobility OEM
accelerates product development and primes GO for discussions with additional private, strategic, and global institutional investors. Investment bank TD Cowen acted as adviser to the transaction. GO is solving fundamental fleet electrification problems with the integration of key
More news about: Indigo Technologies
Oct 02, 2025, 16:15 ET Neptune Insurance Holdings Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Initial Public Offering
& Co. LLC, Evercore ISI, Deutsche Bank Securities, Keefe, Bruyette & Woods, a Stifel Company, Mizuho, Piper Sandler, Raymond James and TD Securities acted as joint bookrunners. Dowling & Partners Securities LLC acted as co-manager. A registration statement relating
More news about: Neptune Flood
Oct 02, 2025, 13:00 ET Relatório da TD SYNNEX revela que IA, serviços e especialização estão impulsionando a próxima onda de crescimento de TI
Instagram. Direitos autorais 2025 TD SYNNEX Corporation. Todos os direitos reservados. TD SYNNEX, o logotipo da TD SYNNEX e todos os outros nomes e slogans de empresas, produtos e serviços da TD SYNNEX são marcas registradas da TD SYNNEX Corporation. Outros nomes e marcas comerciais
More news about: TD SYNNEX
Oct 02, 2025, 11:00 ET ATD Research: TD Professionals Use a Variety of Skills to Align Learning Technologies With Goals
percent of TD professionals are skilled in conducting organizational needs assessments to explore the potential need for a new learning technology. Nearly half of TD professionals find it difficult to conduct these assessments. Nearly two-thirds of TD professionals
More news about: Association for Talent Development (ATD)
Oct 01, 2025, 08:00 ET If you purchased certain U.S. Treasury notes or bonds from April 3, 2018 through May 10, 2019, you may be entitled to receive compensation
This is not a solicitation from a lawyer. On September 29, 2024, TD Securities (USA) LLC ("TD") entered into a deferred prosecution agreement (DPA) with the United States, Department of Justice, Criminal Division, Fraud
More news about: United States Department of Justice
Sep 30, 2025, 20:00 ET oneZero appoints Asiff Hirji, Former Coinbase & Ameritrade President, to Board of Directors
nearly fourfold, and raising $300M at an $8B valuation. Earlier, Asiff played similarly transformative roles as the President of TD Ameritrade through a period of significant growth in its brokerage business, and as Chairman of the Board at Saxo Bank, a regulated European bank specialising
More news about: oneZero Financial Systems
Sep 30, 2025, 20:00 ET oneZero appoints Asiff Hirji, Former Coinbase & Ameritrade President, to Board of Directors
nearly fourfold, and raising $300M at an $8B valuation. Earlier, Asiff played similarly transformative roles as the President of TD Ameritrade through a period of significant growth in its brokerage business, and as Chairman of the Board at Saxo Bank, a regulated European bank specialising
More news about: oneZero Financial Systems
Sep 30, 2025, 17:32 ET Neptune Insurance Holdings Inc. Announces Pricing of Initial Public Offering
& Co. LLC, Evercore ISI, Deutsche Bank Securities, Keefe, Bruyette & Woods, a Stifel Company, Mizuho, Piper Sandler, Raymond James and TD Securities are acting as joint bookrunners. Dowling & Partners Securities LLC is acting as co-manager. The offering is being
More news about: Neptune Flood
Sep 29, 2025, 14:17 ET Once Upon a Farm Announces Filing of Registration Statement for Proposed Initial Public Offering
William Blair are acting as bookrunning managers for the proposed offering. Barclays, Evercore ISI, Deutsche Bank Securities, Oppenheimer & Co., and TD Cowen are acting as bookrunners for the proposed offering. Drexel Hamilton and Siebert Williams Shank are acting as co-managers for the proposed offering.
More news about: Once Upon a Farm, PBC
Sep 29, 2025, 10:13 ET Connecticut Sun and TD Bank Host "Bank on Her" Event
Carolinas and Florida. In addition, TD Auto Finance, a division of TD Bank, N.A., offers vehicle financing and dealer commercial services. TD Bank and its subsidiaries also offer customized private banking and wealth management services through TD Wealth®. TD Bank is headquartered in Mount Laurel,
More news about: Connecticut Sun
Sep 28, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, for the treatment of adult patients with non-transfusion-dependent (NTD) and transfusion-dependent (TD) alpha- or beta-thalassemia by three months to December 7, 2025." On news of the delayed review, Agios's stock price fell $4.48
More news about: Pomerantz LLP
Sep 25, 2025, 18:00 ET ATD, AI Expert Josh Cavalier Collaborate to Deliver AI Education to Talent Development Professionals
president and CEO, concurred with Cavalier on the importance of bringing this course to the TD community. "This is critical time for professionals in our field to learn how to harness the power of AI," he said. "The TD field has an unprecedented opportunity to transform the way people learn and increase the
More news about: Association for Talent Development (ATD)
Sep 25, 2025, 17:00 ET Realty Income Prices $800 Million Dual-Tranche Offering of Senior Unsecured Notes
closing conditions. The active joint book-running managers for the offering are Wells Fargo Securities, Barclays, BofA Securities, Mizuho, and TD Securities. A copy of the prospectus supplement and prospectus, when available, related to this offering may be obtained by contacting: Wells
More news about: Realty Income Corporation
Sep 25, 2025, 16:30 ET FSK Completes Public Offering of $400,000,000 6.125% Unsecured Notes Due 2031
SMBC Nikko Securities America, Inc., Truist Securities, Inc., MUFG Securities Americas Inc., Mizuho Securities USA LLC, TD Securities (USA) LLC, HSBC Securities (USA) Inc. and RBC Capital Markets, LLC are acting
More news about: Future Standard
Sep 25, 2025, 12:01 ET HashiCorp Previews the Future of Agentic Infrastructure Automation with Project infragraph
by AWS, Microsoft, Arrow, Atyeti, Coder, Clumio, Datadog, Gomboc, Google Cloud, Mondoo, Overmind, Palo Alto Networks, Red Hat, River Point Technology, TD Synnex, and Wiz. To register for a free virtual pass to HashiConf — with access to a dedicated platform to view the live-streamed keynotes, educational
More news about: IBM
Sep 25, 2025, 08:00 ET National Ataxia Foundation Partners with Biogen to Bring Bill Nye "the Science Guy" Back To the Lab With New Series About Friedreich Ataxia
https://pmc.ncbi.nlm.nih.gov/articles/PMC7397644/#Sec9 Wallace SE, Bird TD. Molecular genetic testing for hereditary ataxia: what every neurologist should know. Neurol Clin Pract. 2018;8(1):27-32.
More news about: National Ataxia Foundation